Teleflex (BSP:T1FX34) Cyclically Adjusted Revenue per Share: R$28.97 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:T1FX34 Teleflex Inc BSP:T1FX34
76 GF Score
Price R$69.78
GF Value R$92.61
! 7 Warning Signs
View Full Analysis

What is Teleflex Cyclically Adjusted Revenue per Share?

Teleflex BSP:T1FX34 76 Cyclically Adjusted Revenue per Share is R$28.97 as of Mar. 2026. GuruFocus rates BSP:T1FX34 with a GF Score™ of 76/100 and a GF Value™ of R$92.61. The stock has 7 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Teleflex's adjusted revenue per share for the three months ended in Mar. 2026 was R$6.479. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is R$28.97 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Teleflex's average Cyclically Adjusted Revenue Growth Rate was 1.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 0.40% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 3.60% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 3.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Teleflex was 13.50% per year. The lowest was -4.60% per year. And the median was 3.00% per year.

As of today (2026-08-05), Teleflex's current stock price is R$69.78. Teleflex's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was R$28.97. Teleflex's Cyclically Adjusted PS Ratio of today is 2.41.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Teleflex was 9.24. The lowest was 1.81. And the median was 4.69.


Teleflex  (BSP:T1FX34) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Teleflex's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=69.78/28.97
=2.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Teleflex was 9.24. The lowest was 1.81. And the median was 4.69.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Teleflex Cyclically Adjusted Revenue per Share Related Terms


Teleflex Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Teleflex's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teleflex Cyclically Adjusted Revenue per Share Chart

Teleflex Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 27.16 29.74 25.98 34.73 31.30

Teleflex Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.98 32.55 31.25 31.30 28.97

BSP:T1FX34 vs STVN, MMED, MMSI: Cyclically Adjusted Revenue per Share Comparison

For the Medical Instruments & Supplies subindustry, Teleflex's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Teleflex Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Teleflex's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Teleflex's Cyclically Adjusted PS Ratio falls into.


BSP:T1FX34
76GF Score
Teleflex Inc BSP:T1FX34
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Teleflex Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Teleflex's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=6.479/330.2130*330.2130
=6.479

Current CPI (Mar. 2026) = 330.2130.

Teleflex Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 3.431 241.018 4.701
201609 3.124 241.428 4.273
201612 3.659 241.432 5.005
201703 3.273 243.801 4.433
201706 3.721 244.955 5.016
201709 3.595 246.819 4.810
201712 4.205 246.524 5.632
201803 4.124 249.554 5.457
201806 5.046 251.989 6.612
201809 5.351 252.439 7.000
201812 5.318 251.233 6.990
201903 5.020 254.202 6.521
201906 5.349 256.143 6.896
201909 5.661 256.759 7.281
201912 5.921 256.974 7.609
202003 6.524 258.115 8.346
202006 6.228 257.797 7.977
202009 7.168 260.280 9.094
202012 7.729 260.474 9.798
202103 7.535 264.877 9.394
202106 7.564 271.696 9.193
202109 7.790 274.310 9.378
202112 9.087 278.802 10.763
202203 6.737 287.504 7.738
202206 7.511 296.311 8.370
202209 7.620 296.808 8.478
202212 8.419 296.797 9.367
202303 7.831 301.836 8.567
202306 7.622 305.109 8.249
202309 7.793 307.789 8.361
202312 -5.056 306.746 -5.443
202403 7.753 312.332 8.197
202406 8.526 314.175 8.961
202409 9.004 315.301 9.430
202412 -7.231 315.605 -7.566
202503 5.194 319.799 5.363
202506 9.769 322.561 10.001
202509 11.069 324.800 11.253
202512 -4.912 324.054 -5.005
202603 6.479 330.213 6.479

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of R$28.97 mean?
Teleflex (BSP:T1FX34) has a Cyclically Adjusted Revenue per Share of R$28.97 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Teleflex and its competitors.
Is Teleflex's Cyclically Adjusted Revenue per Share too high?
Teleflex's current Cyclically Adjusted Revenue per Share is R$28.97. Overall, Teleflex has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does Teleflex's Cyclically Adjusted Revenue per Share compare to STVN and MMED?
Teleflex's Cyclically Adjusted Revenue per Share of R$28.97 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Teleflex and its competitors. Teleflex's current Cyclically Adjusted Revenue per Share is R$28.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teleflex stock overvalued right now?
Teleflex (BSP:T1FX34) has a current Cyclically Adjusted Revenue per Share of R$28.97. The stock's GF Value™ is R$92.61, compared to a current price of R$69.78 — trading 24.7% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is R$28.97. Teleflex's overall GF Score™ is 76/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Teleflex (BSP:T1FX34), the current Cyclically Adjusted Revenue per Share is R$28.97 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Teleflex (BSP:T1FX34) Overvalued in 2026?

Based on GuruFocus' analysis, Teleflex stock appears to be undervalued. The current stock price of R$69.78 is trading 24.7% below its estimated GF Value™ of R$92.61.

Key valuation signals for BSP:T1FX34:

  • Cyclically Adjusted Revenue per Share: R$28.97
  • GF Value™: R$92.61 vs. price of R$69.78 (24.7% below fair value)
  • GF Score™: 76/100 with 7 warning signs

No single metric tells the full story. See the BSP:T1FX34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Teleflex Business Description

Address 550 East Swedesford Road, Suite 400, Wayne, PA, USA, 19087
Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.
76GF Score

Get the complete analysis for BSP:T1FX34

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$69.78
Price
R$92.61
GF Value